Page last updated: 2024-10-21

4-aminopyridine and Mental Disorders

4-aminopyridine has been researched along with Mental Disorders in 1 studies

Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.

Research Excerpts

ExcerptRelevanceReference
"Severity of 6-OHDA-induced Parkinsonism was assessed by conventional behavioural tests."1.43Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation. ( Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Mahmudi, M; Piri, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haghdoost-Yazdi, H1
Piri, H1
Faraji, A1
Fraidouni, N1
Dargahi, T1
Mahmudi, M1
Alipour Heidari, M1

Other Studies

1 other study available for 4-aminopyridine and Mental Disorders

ArticleYear
Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
    Neurological research, 2016, Volume: 38, Issue:4

    Topics: 4-Aminopyridine; Adrenergic Agents; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; D

2016